Betamethasone Valerate
Who holds supplier records for Betamethasone Valerate? 11 organisations hold a current record for Betamethasone Valerate: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Italy (1), Netherlands (1), Israel (1) and 4 other countries (4); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Betamethasone Valerate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/betamethasone-valerate
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Betamethasone Valerate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Farmabios S.p.A.ItalyCEP Company GMP cert on recordActive DMF 12749 · latest filing Nov 1997
- HENAN LIHUA PHARMACEUTICAL CO LTDCEPActive DMF 35865 · latest filing Jan 2022
- SYMBIOTEC PHARMALAB PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 22062 · latest filing Oct 2008
- TAPI NL BVNetherlandsCEPActive DMF 4118 · latest filing Apr 1981
- HALCYON LABS PRIVATE LTDIndiaActive DMF 21320 · latest filing Feb 2008
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 15004 · latest filing Aug 2000
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDActive DMF 38063 · latest filing Aug 2023
- ChinaCEP Company GMP cert on record
- SpainCEP Company GMP cert on record
- MalaysiaCEP
- GlaxoSmithKline Research & Development LimitedUnited KingdomCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Betamethasone Valerate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SYMBIOTEC PHARMALAB LIMITED Indore | IN | CEP 2008-307 - Rev 01 Betamethasone valerate, Micronised | Apr 2026 | Inspected Mar 2026 Germany |
| AURISCO PHARMACEUTICAL CO., LTD. Tiantai | CN | CEP 2021-120 - Rev 02 Betamethasone valerate | Sept 2025 | Inspected Dec 2023 Germany |
| TAPI NL B.V. Amsterdam | NL | CEP 2003-095 - Rev 05 Betamethasone valerate | Feb 2025 | — |
| GlaxoSmithKline Research & Development Limited London | GB | CEP 2002-219 - Rev 09 Betamethasone valerate, Micronised | Oct 2024 | — |
| HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang | CN | R0-CEP 2021-509 - Rev 00 Betamethasone valerate | Jul 2022 | — |
| CURIA SPAIN S.A.U. Boecillo | ES | R1-CEP 2003-022 - Rev 02 Betamethasone valerate | Aug 2021 | — |
| FARMABIOS S.p.A Gropello Cairoli | IT | R1-CEP 2002-078 - Rev 03 Betamethasone valerate, Micronised | Mar 2021 | — |
| SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. Perai | MY | R1-CEP 2008-215 - Rev 00 Betamethasone valerate | Jun 2015 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (10)
Organisations whose Type II DMFs for Betamethasone Valerate are no longer active. These show a past filing, not current supply.
Show all 10 historical records
- Italy · Inactive DMF 22406 · filed Jan 2009
- India · Inactive DMF 22651 · filed Dec 2008
- HOECHST MARION ROUSSEL SAInactive DMF 7310 · filed Feb 1988
- QUATRUMInactive DMF 7049 · filed Jul 1987
- United States · Inactive DMF 6405 · filed Jun 1986
- SCHERING AGInactive DMF 5863 · filed May 1985
- DIOSYNTH BVInactive DMF 5554 · filed Oct 1984
- COMPANIA ESPANOLA DE SINTESIS QUIMICA SAInactive DMF 5465 · filed Jul 1984
- GLAXOCHEM LTDInactive DMF 4578 · filed Jun 1982
- Portugal · Inactive DMF 4397 · filed Dec 1981
Overview
Betamethasone Valerate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1497).
Chemical identity
- IUPAC name
- [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate
- Canonical SMILES
- CCCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CO
- InChIKey
- SNHRLVCMMWUAJD-SUYDQAKGSA-N
- Synonyms
- Audavate, Audavate rd, Betacap, Betaderm, Betamethasone 17-valerate, Betamethasone (as valerate), Betamethasone valerate, Betamethasoni valeras, Betameth val in coal tar, Betatrex, Beta-val, Betesil
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Corticosteroid
- Mechanism of action
- Corticosteroid Hormone Receptor Agonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Betamethasone Valerate?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Betamethasone Valerate: Farmabios S.p.A. (Italy), HENAN LIHUA PHARMACEUTICAL CO LTD, SYMBIOTEC PHARMALAB PRIVATE LTD (India), TAPI NL BV (Netherlands), HALCYON LABS PRIVATE LTD (India), Taro Pharmaceutical Industries Ltd. (Israel), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD and Aurisco Pharmaceutical Co.,ltd (China), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Betamethasone Valerate Drug Master Files are active?
Farmabios S.p.A. (DMF 12749), HENAN LIHUA PHARMACEUTICAL CO LTD (DMF 35865), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 22062), TAPI NL BV (DMF 4118), HALCYON LABS PRIVATE LTD (DMF 21320), Taro Pharmaceutical Industries Ltd. (DMF 15004) and ZHEJIANG XIANJU PHARMACEUTICAL CO LTD (DMF 38063). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Betamethasone Valerate records mean?
10 organisations have only inactive Type II DMFs for Betamethasone Valerate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Betamethasone Valerate have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Betamethasone Valerate on the EDQM register, including SYMBIOTEC PHARMALAB LIMITED Indore (IN), AURISCO PHARMACEUTICAL CO., LTD. Tiantai (CN), TAPI NL B.V. Amsterdam (NL), GlaxoSmithKline Research & Development Limited London (GB), HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang (CN) and CURIA SPAIN S.A.U. Boecillo (ES) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Betamethasone Valerate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Betamethasone Valerate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.